Previous close | 3.8000 |
Open | 3.7500 |
Bid | 0.0000 x 900 |
Ask | 0.0000 x 1000 |
Day's range | 3.6400 - 3.8400 |
52-week range | 2.5200 - 16.7600 |
Volume | |
Avg. volume | 1,032,885 |
Market cap | 2.651B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.5170 |
Earnings date | 15 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.57 |
Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDTRoivant will host an investor day on Wednesday, September 28 at 11:00 a.m. EDT BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Monday, August 15, 2022 to report its financi
Does the July share price for Roivant Sciences Ltd. ( NASDAQ:ROIV ) reflect what it's really worth? Today, we will...
It's been a good week for Roivant Sciences Ltd. ( NASDAQ:ROIV ) shareholders, because the company has just released its...